Expert oncologists center discussion on a clinical scenario to highlight optimal treatment strategies in metastatic triple-negative breast cancer.
EP. 1: A Brief Overview of Treatment Options for Triple-Negative Breast Cancer
EP. 2: Patient Scenario: A 44-Year-Old Woman With Metastatic TNBC
EP. 3: First-Line Treatment for Metastatic TNBC: Pembrolizumab + Chemotherapy
EP. 4: Future Treatment Strategies for Triple-Negative Breast Cancer
Isa-KRd Elicits MRD-Negative Remissions in Newly Diagnosed, High-Risk Myeloma
KIT Inhibitors Lead to Shift in Treatment of Systemic Mastocytosis
Smoldering Multiple Myeloma Management Hinges on the Debate Between Treatment and Observation
Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis